Key Takeaways
- • CVC Capital Partners' Fund VII holds a 47% stake in Milan-listed drugmaker Recordati SpA, acquired in a 2018 deal with the founding family, according to the primary report.
- • The position has performed well, but CVC has not secured a straightforward disposal, leaving the holding without a clear exit path.
- • Sale talks in 2024 produced no formal transaction, leaving CVC reliant on possible internal fund-to-fund transfers that could draw scrutiny over valuation and self-dealing.
- • The case illustrates a broader European private equity challenge: completing formal exits for aging assets when external buyers are scarce, which affects fund life cycles and capital returns.
Summary
As first reported by Bloomberg News and covered by Traders Union, CVC Capital Partners' Fund VII holds a 47% stake in Recordati SpA, the Milan-listed drugmaker, following a 2018 transaction with the company's founding family. The investment has performed well, but CVC has yet to execute a clean sale of the asset, drawing closer scrutiny to its exit strategy.
The situation highlights a broader practice in private equity in which mature assets are moved into another buyout fund, often managed by the same firm, when a traditional third-party buyer fails to emerge. While this approach can extend ownership timelines, it raises concerns about self-dealing and valuation when seller and buyer are closely linked.
Sale talks for Recordati took place in 2024, but no formal transaction materialized. The absence of a clean outcome leaves CVC facing the same industry-wide question of how to monetize successful holdings when external demand is insufficient and internal fund-to-fund sales risk deeper regulatory and investor scrutiny.
The Recordati case reflects wider pressure on European buyout groups to find exits for older investments. Delays in selling can affect fund life cycles, capital returns and investor expectations, particularly for firms managing aging assets in a market where formal transactions are difficult to complete.
The situation highlights a broader practice in private equity in which mature assets are moved into another buyout fund, often managed by the same firm, when a traditional third-party buyer fails to emerge. While this approach can extend ownership timelines, it raises concerns about self-dealing and valuation when seller and buyer are closely linked.
Sale talks for Recordati took place in 2024, but no formal transaction materialized. The absence of a clean outcome leaves CVC facing the same industry-wide question of how to monetize successful holdings when external demand is insufficient and internal fund-to-fund sales risk deeper regulatory and investor scrutiny.
The Recordati case reflects wider pressure on European buyout groups to find exits for older investments. Delays in selling can affect fund life cycles, capital returns and investor expectations, particularly for firms managing aging assets in a market where formal transactions are difficult to complete.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.